Eyebright Medical has spent 683 million yuan to acquire a 68.31 percent controlling stake in Delta Medical, officially bringing sports medicine into the group's second growth curve. Delta Medical founder Li Jianbo said the company has relied on independent research and development to leap from being an agent to a leading domestic manufacturer, with its rotator cuff anchors capturing a 28.6 percent domestic market share in 2025, firmly ranking first in the industry. The fourth round of volume-based procurement in 2023 included sports medicine consumables, and Delta Medical's core products were selected for the Group A tier, opening up the national grassroots hospital market through price-for-volume swaps and breaking the long-standing monopoly of foreign capital. After the merger, the two sides will form synergies and jointly tackle cutting-edge products such as total artificial meniscus and 3D cartilage repair scaffolds, filling the gap in high-end biomimetic consumables in China.
Eyebright Medical Technology Beijing Co LtdEyebright Medical acquires 68.31% controlling stake in Delta Medical for 683 million yuan, expanding into sports medicine.